手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 集団薬物動態モデル(Population Pharmacodynamic Modeling)× | ミカエリス・メンテン速度論× | |
|---|---|---|
| 分野 | 薬理学 | 薬理学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1992 | 1913 |
| 提唱者≠ | Lewis Sheiner and Stephen Roush | Leonor Michaelis and Maud Menten |
| 種類≠ | dose-response modeling | mechanistic model |
| 原典≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ |
| 別名 | PopPD, population PD, hierarchical PD modeling | MM kinetics, Michaelis constant, Vmax |
| 関連≠ | 3 | 2 |
| 概要≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. |
| ScholarGateデータセット ↗ |
|
|